Company intelligence / Profile preview

Shanxi Dongjin Pharmaceutical

Jinzhong, Shanxi, China

Ownership: Private
Development stage: Other

Overview

Shanxi Dongjin Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of various drug formulations. The company's portfolio includes a wide range of products such as tablets, capsules, granules, and traditional Chinese medicines (TCM). Key products often include over-the-counter (OTC) medications for respiratory ailments, pain relief, and nutritional supplements. Operating primarily within the domestic Chinese market, the company maintains multiple GMP-certified production lines to ensure high-quality output for its diverse therapeutic offerings.

Therapeutic areas: GastroenterologyNeurologyInfectious DiseasesMetabolic Disorders
Modalities: Small moleculeTraditional Chinese Medicine
Industry: Biotech

Beyond the preview

Go deeper on Shanxi Dongjin Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanxi Dongjin Pharmaceutical.

Explore the full profile